Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NJ Innovation Institute, Rutgers form Continuous Mfg. Institute | Contract Pharma

What are you searching for?

Sign in
Breaking News

NJ Innovation Institute, Rutgers form Continuous Mfg. Institute

Will serve as a center of excellence to advance new pharmaceutical manufacturing technologies

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

The New Jersey Innovation Institute, an NJIT Corp., and Rutgers University have formed the New Jersey Continuous Manufacturing Institute (NJCMI) that will serve as a center of excellence to advance new pharmaceutical manufacturing technologies.

The NJCMI will combine new technologies, infrastructure, facilities and technical expertise to support the development and continuous manufacture of pharmaceutical products. It will also provide training, education and workforce development.

The NJCMI facility features Process Development Pilot Plants for both solid dosage forms and biologics, as well as cGMP suites for production. It also provides individual Unit Operations labs for process optimization and control, modeling and automation. It also offers designated classrooms and training labs for collaborative learning experiences and workforce development.

Dr. Donald H. Sebastian, president of NJII said, “This partnership with Rutgers builds on over a decade of leading edge R&D, and deep faculty expertise that NJCMI can leverage to make available pilot-scale technologies that meet pharmaceutical industry demands for higher production volume, greater efficiency and reduced cost.  I expect the center will be a strong magnet attracting all the links of the pharmaceutical value chain to make New Jersey a place of business.”

Dr. Christopher J. Molloy, senior vice president, Rutgers office of research & economic development stated, “NJCMI brings together a complete range of expertise and knowledge to develop innovative biopharmaceutical processing technologies. Our team is led by a core of professionals with more than 100 years of combined experience in biopharmaceutical manufacturing process development, biochemical and chemical engineering. Together, Rutgers and NJII, through the NJCMI, are meeting the challenges for cost effective approaches to the continuous production of both new and existing classes of pharmaceuticals.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics